Explore 2 Growth

2 investments found
Lipigon Pharmaceuticals AB

Lipigon Pharmaceuticals AB

Lipigon utvecklar läkemedel för sjukdomar som beror på störningar i hur fetter hanteras i kroppen.
Funded SEK 7,996,815
Target SEK 7,996,815
Capital Target SEK 9,996,090
Min. Raise SEK 7,996,815
Percent of Equity Offered 33%
Valuation of equity SEK 30000000
End Date 11 February 2019
2 Growth
View Investment

EMPE Diagnostics

EMPE Diagnostics offers rapid and easy to use diagnostic solutions for infectious diseases with an initial focus on tuberculosis.
Funded SEK 9,722,385
Target SEK 4,000,000
Capital Target SEK 9,722,385
Min. Raise SEK 3,988,710
Percent of Equity Offered 42%
Valuation of equity SEK 23000000
End Date 10 August 2018
2 Growth
View Investment